Inosine pranobex (Delimmun) has a number of immunomodulatory effects, including inducing T-lymphocyte differentiation, augmenting macrophage and NK cell functions, and stimulating IL-2 production. Through these effects and others, isoprinosine shows antiviral activity and has applications against subacute sclerosing panencephalitis. It also restores depressed immune responses in Y patients after irradiation and reduces the incidence of infection in leukemia patients undergoing chemotherapy. It is most commonly used to treat the rare measles complication subacute sclerosing panencephalitis in conjunction with intrathecal interferon therapy.
Molecular Weight:
1115.23
Purity:
99.78%
CAS Number:
[36703-88-5]
Formula:
C52H78N10O17
Target:
HIV Protease|||IL Receptor|||HSV|||Virus Protease|||Interleukin
T3614
* VAT and and shipping costs not included. Errors and price changes excepted
